XRAY logo

DENTSPLY SIRONA (XRAY)

Profile

Full Name

DENTSPLY SIRONA Inc.

Ticker Symbol

XRAY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

August 12, 1987

Indexes

Not included

Website

http://www.dentsplysirona.com

Employees

14000

Key Details

Price

$16.59(+4.50%)

Market cap

$3.31B(Mid cap)

Last Dividend

$0.16

TTM Dividend yield

3.86%

Annual revenue

$3.79B(-4.34% YoY)

Annual EPS

-$4.48(-622.58% YoY)

PE ratio

-

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $16.59
    XRAY price is $16.59

    30-Day Relative Volume

    0.87
    XRAY 30-day relative volume is 0.87

    Price Performance

    Price Today change

    +4.5%
    XRAY price is up +4.5% today

    Price YTD change

    -12.57%
    XRAY price is down -12.57% since January 1st

    Price 1-year change

    -32.62%
    XRAY price is down -32.62% year-on-year

    Price 3-year change

    -54.16%
    XRAY price is down -54.16% over the past 3 years

    Price Range

    Price All-time high

    $69.54
    XRAY price is currently -76.14% below its historical high of $69.54

    Price 3-year low

    $12.16
    XRAY price is currently +36.47% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.31B
    XRAY market capitalization is $3.31 billion

    Market cap 3-year change

    -57.47%
    XRAY market capitalization is down -57.47% over the past 3 years

    Market cap All-time high

    $15.75B
    XRAY market capitalization is currently -79.00% below its historical high of $15.75 billion

    Market cap sector rank

    86.33%
    XRAY market capitalization is higher than 86.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.63%
    XRAY shares outstanding is down -1.63% year-on-year

    Shares Outstanding 3-Year Change

    -7.22%
    XRAY shares outstanding is down -7.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.92
    XRAY beta is 0.92

    200-day SMA

    $18.56
    XRAY price is currently -10.57% below its 200-day simple moving average

    50-day SMA

    $15.34
    XRAY price is currently +8.15% above its 50-day simple moving average

    RSI

    52.27
    XRAY 14-day relative strength index is 52.27

    Volume

    0.87
    XRAY 30-day relative volume is 0.87

    ATR

    $0.41
    XRAY average true range is $0.41

    10-day Historical Volatility

    25.46%
    XRAY 10-day historical volatility is 25.46%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.16
    XRAY last dividend was $0.16 per share, with an ex-dividend date of June 27, 2025

    Next Dividend

    -
    XRAY next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.64
    XRAY annual dividend per share is $0.64

    Dividend per share Sector Rank

    27.06%
    XRAY annual dividend per share is higher than 27.06% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +14.29%
    XRAY annual dividend per share is up +14.29% year-on-year

    Dividend per share 3-Year Change

    +48.84%
    XRAY annual dividend per share is up +48.84% over the past 3 years

    Dividend yield

    Dividend yield

    3.86%
    XRAY annual dividend yield is 3.86%

    Dividend yield Sector Rank

    79.76%
    XRAY annual dividend yield is higher than 79.76% of companies in Healthcare sector

    Other

    Payout ratio

    -13.85%
    XRAY annual payout ratio is -13.85%

    Dividends paid

    $126.00M
    XRAY annual dividends paid is $126.00 million

    Free cash flow

    $281.00M
    XRAY annual free cash flow is $281.00 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.79B
    XRAY annual revenue is $3.79 billion

    Revenue Analysts estimate

    $3.64B
    XRAY annual revenue is currently +4.10% higher than the consensus analysts' forecast

    Revenue 1-year change

    -4.34%
    XRAY annual revenue is down -4.34% year-on-year

    Revenue Sector rank

    89.82%
    XRAY annual revenue is higher than 89.82% of companies in Healthcare sector

    EPS

    EPS

    -$4.48
    XRAY annual earnings per share is -$4.48

    EPS Analysts estimate

    $1.86
    XRAY annual earnings per share is currently -340.45% lower than the consensus analysts' forecast

    EPS 1-year change

    -622.58%
    XRAY annual earnings per share is down -622.58% year-on-year

    EPS Sector rank

    21.66%
    XRAY annual earnings per share is higher than 21.66% of companies in Healthcare sector

    Profit

    Gross profit

    $1.96B
    XRAY annual gross profit is $1.96 billion

    Gross margin

    51.62%
    XRAY annual gross profit margin is 51.62%

    Operating profit

    $188.00M
    XRAY annual operating income is $188.00 million

    Operating margin

    4.96%
    XRAY annual operating profit margin is 4.96%

    Net income

    -$910.00M
    XRAY annual net profit is -$910.00 million

    Net margin

    -23.99%
    XRAY annual net profit margin is -23.99%

    Expenses

    Total expenses

    $3.60B
    XRAY annual total expenses is $3.60 billion

    Operating expenses

    $1.77B
    XRAY annual total operating expenses is $1.77 billion

    Cost of goods sold

    $1.83B
    XRAY annual cost of goods sold is $1.83 billion

    Selling, general & administrative expenses

    $1.60B
    XRAY annual SGA is $1.60 billion

    Depreciation and amortization

    $349.00M
    XRAY annual depreciation & amortization is $349.00 million

    Interest expense

    $69.00M
    XRAY annual interest expense is $69.00 million

    Income tax

    -$26.00M
    XRAY annual income tax is -$26.00 million

    EBIT & EBITDA

    EBIT

    -$867.00M
    XRAY annual earnings before interest & taxes is -$867.00 million

    EBITDA

    -$518.00M
    XRAY annual EBITDA is -$518.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.75B
    XRAY annual total assets is $5.75 billion

    Non current assets

    $4.01B
    XRAY annual long term assets is $4.01 billion

    Current assets

    $1.75B
    XRAY annual total current assets is $1.75 billion

    Cash and cash equivalents

    $272.00M
    XRAY annual cash & cash equivalents is $272.00 million

    Accounts receivable

    $556.00M
    XRAY annual accounts receivable is $556.00 million

    Inventory

    $564.00M
    XRAY annual inventory is $564.00 million

    Liabilities

    Total liabilities

    $3.81B
    XRAY annual total liabilities is $3.81 billion

    Long term liabilities

    $2.22B
    XRAY annual total long term liabilities is $2.22 billion

    Current liabilities

    $1.59B
    XRAY annual total current liabilities is $1.59 billion

    Accounts payable

    $241.00M
    XRAY annual accounts payable is $241.00 million

    Debt

    Total debt

    $2.27B
    XRAY annual total debt is $2.27 billion

    Total debt 1-year change

    -1.17%
    XRAY annual total debt is down -1.17% year-on-year

    Long term debt

    $1.68B
    XRAY annual long term debt is $1.68 billion

    Short term debt

    $595.00M
    XRAY annual short term debt is $595.00 million

    Equity & Capital

    Shareholders equity

    $1.94B
    XRAY annual stockholders equity is $1.94 billion

    Book value

    $1.94B
    XRAY annual book value is $1.94 billion

    Retained earnings

    -$835.00M
    XRAY annual retained earnings is -$835.00 million

    Working capital

    $157.00M
    XRAY annual working capital is $157.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $461.00M
    XRAY annual cash flow from operations is $461.00 million

    Cash from operations 1-year change

    +22.28%
    XRAY annual cash flow from operations is up +22.28% year-on-year

    Cash from investing

    -$197.00M
    XRAY annual cash flow from investing activities is -$197.00 million

    Cash from investing 1-year change

    -121.35%
    XRAY annual cash flow from investing activities is down -121.35% year-on-year

    Cash from financing

    -$302.00M
    XRAY annual cash flow from financing activities is -$302.00 million

    Cash from financing 1-year change

    +1.63%
    XRAY annual cash flow from financing activities is up +1.63% year-on-year

    CAPEX

    CAPEX

    $180.00M
    XRAY annual capital expenditures is $180.00 million

    CAPEX 1-year change

    +20.81%
    XRAY annual capital expenditures is up +20.81% year-on-year

    Free Cash Flow

    Free cash flow

    $281.00M
    XRAY annual free cash flow is $281.00 million

    Free cash flow 1-year change

    +23.25%
    XRAY annual free cash flow is up +23.25% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    51.62%
    XRAY annual gross profit margin is 51.62%

    Operating margin

    4.96%
    XRAY annual operating profit margin is 4.96%

    Net margin

    -23.99%
    XRAY annual net profit margin is -23.99%

    ROA & ROE

    ROA

    -13.87%
    XRAY annual return on assets is -13.87%

    ROE

    -34.75%
    XRAY annual return on equity is -34.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    XRAY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    XRAY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.65
    XRAY price to book ratio is 1.65

    PB ratio Sector rank

    52.33%
    XRAY price to book ratio is higher than 52.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.89
    XRAY price to sales ratio is 0.89

    PS ratio Sector rank

    23.31%
    XRAY price to sales ratio is higher than 23.31% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.33B
    XRAY enterprise value is $5.33 billion

    Enterprise value Sector rank

    88.46%
    XRAY enterprise value is higher than 88.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -10.43
    XRAY EV/EBITDA is -10.43

    EV/EBITDA Sector rank

    12.79%
    XRAY EV/EBITDA is higher than 12.79% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.10
    XRAY annual current ratio is 1.10

    Quick ratio

    0.74
    XRAY annual quick ratio is 0.74

    Leverage

    Debt to equity

    1.10
    XRAY annual debt to equity ratio is 1.10

    Interest coverage ratio

    -12.57
    XRAY annual interest coverage ratio is -12.57

    Risk & Stability

    Piotroski F-Score

    5
    XRAY piotroski f-score is 5

    Altman Z-Score

    0.51
    XRAY altman z-score is 0.51

    Analyst ratings

    Recent major analysts updates

    May 12, 25 Barrington Research
    Outperform
    May 9, 25 UBS
    Buy
    Apr 30, 25 Piper Sandler
    Neutral
    Mar 13, 25 Needham
    Hold
    Mar 13, 25 Mizuho
    Neutral
    Feb 28, 25 Wells Fargo
    Equal-Weight
    Feb 28, 25 Needham
    Buy
    Feb 28, 25 Barrington Research
    Outperform
    Feb 28, 25 Baird
    Neutral
    Feb 14, 25 Wells Fargo
    Equal-Weight

    Institutional Ownership

    Screeners with XRAY included

    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    Companies with growing dividends
    All stocks
    High yield dividend stocks
    • What is the ticker symbol for DENTSPLY SIRONA?
    • Does DENTSPLY SIRONA pay dividends?
    • What sector is DENTSPLY SIRONA in?
    • What industry is DENTSPLY SIRONA in?
    • What country is DENTSPLY SIRONA based in?
    • When did DENTSPLY SIRONA go public?
    • Is DENTSPLY SIRONA in the S&P 500?
    • Is DENTSPLY SIRONA in the NASDAQ 100?
    • Is DENTSPLY SIRONA in the Dow Jones?
    • When was DENTSPLY SIRONA's last earnings report?
    • When does DENTSPLY SIRONA report earnings?
    • Should I buy DENTSPLY SIRONA stock now?

    What is the ticker symbol for DENTSPLY SIRONA?

    The ticker symbol for DENTSPLY SIRONA is NASDAQ:XRAY

    Does DENTSPLY SIRONA pay dividends?

    Yes, DENTSPLY SIRONA pays dividends. The last payment was $0.16, with an ex-dividend date on June 27, 2025

    What sector is DENTSPLY SIRONA in?

    DENTSPLY SIRONA is in the Healthcare sector

    What industry is DENTSPLY SIRONA in?

    DENTSPLY SIRONA is in the Medical Instruments & Supplies industry

    What country is DENTSPLY SIRONA based in?

    DENTSPLY SIRONA is headquartered in United States

    When did DENTSPLY SIRONA go public?

    DENTSPLY SIRONA's initial public offering (IPO) was on August 12, 1987

    Is DENTSPLY SIRONA in the S&P 500?

    No, DENTSPLY SIRONA is not included in the S&P 500 index

    Is DENTSPLY SIRONA in the NASDAQ 100?

    No, DENTSPLY SIRONA is not included in the NASDAQ 100 index

    Is DENTSPLY SIRONA in the Dow Jones?

    No, DENTSPLY SIRONA is not included in the Dow Jones index

    When was DENTSPLY SIRONA's last earnings report?

    DENTSPLY SIRONA's most recent earnings report was on May 8, 2025

    When does DENTSPLY SIRONA report earnings?

    The next expected earnings date for DENTSPLY SIRONA is Jul 31, 2025

    Should I buy DENTSPLY SIRONA stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page